Concepedia

B. Häring

BH

Statistics

Publications

6

Citations

262

H-Index

6

Active since

1998

Affiliations

University Medical Center Freiburg(Current)

University of Freiburg

B. Häring is an author at University Medical Center Freiburg specializing in medicine, pharmacology, and toxicity management.

Publications per year

1998–2011

6

Publications

6

Phase I and Pharmacokinetic Study of the (6-Maleimidocaproyl)Hydrazone Derivative of Doxorubicin

Clemens Unger, B. Häring, Michael Medinger et al. · Clinical Cancer Research · 2007 · 103 citations · Full text

, , +16

Immunotherapy of patients with hormone‐refractory prostate carcinoma pre‐treated with interferon‐gamma and vaccinated with autologous PSA‐peptide loaded dendritic cells—A pilot study

Bernd Hildenbrand, Brian C. Sauer, O. Kalis et al. · The Prostate · 2007 · 56 citations

, , +17

Metronomic Antiangiogenic Therapy with Capecitabine and Celecoxib in Advanced Tumor Patients – Results of a Phase II Study

Simone Steinbild, J. Arends, Michael Medinger et al. · Oncology Research and Treatment · 2007 · 48 citations

, , +16

Phase II Study with 5-Fluorouracil and Ginkgo biloba Extract (GBE 761 ONC) in Patients with Pancreatic Cancer

Bernhard Hauns, B. Häring, Stephan Köhler et al. · Arzneimittelforschung · 2011 · 22 citations

, , +14

Comparison of 1-Hour and 3-Hours Paclitaxel Infusion Pharmacokinetics: Results from a Randomized Trial

K. Mross, B. Häring, Norbert Holländer et al. · Oncology Research and Treatment · 2002 · 18 citations

, , +17

1–5 of 6